Company Profile
|
Kazia Therapeutics Limited
(NASDAQ: KZIA)
|
3:57 PM EDT, 09/22/23 | |||
|---|---|---|---|---|
| Last: $1.03 | Change: +0.03 | %Change: +3.00% | Volume: 11,646 | |
Detailed Quote
M = Million B = Billion
Price Performance
Management Effectiveness
Profitability
| Open: | $ 0.98 | Volume: | 11,646 | |
|---|---|---|---|---|
| High: | $ 1.03 | Yield(%) | 0.00 | |
| Low: | $ 0.94 | P/E Ratio (ttm): | n/a | |
| Dividend ($): | 4.09 | Market Cap ($): | 23.63M | |
| EPS ($) | n/a | Shares Out: | 23.63M |
| % Price Change (last 4 weeks): | 16.28 |
|---|---|
| % Price Change (last 13 weeks): | -18.70 |
| % Price Change (last 26 weeks): | 4.85 |
| % Price Change (last 52 weeks): | -13.04 |
| % Price Change (year to date): | 62.63 |
| Return on Equity (%): | -132.12 |
|---|---|
| Return on Assets (%): | -64.43 |
| Return on Invested Capital (%): | -79.49 |
| Gross Profit Margin (%): | n/a |
|---|---|
| Net Profit Margin (%): | n/a |
| Operating Profit Margin (%): | 0.00 |
Price & Volume
Company Information
Per Share Data
Valuation Ratios
Financial Strength
|
|
|
| 50-day Moving Average: | $0.96 |
|---|---|
| 200-day Moving Average: | $1.02 |
| Avg. Daily Vol. (last 50 days): | 32,583 |
| Avg. Daily Vol. (last 200 days): | 92,595 |
| 52-wk high: | $1.68 |
| 52-wk low: | $0.50 |
| Bid: | $0.86 |
| Ask: | $1.03 |
|
Kazia Therapeutics Ltd. is a clinical stage oncology company It engages in the pharmaceutical research and development business. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
|
|
Kazia Therapeutics Limited
Three International Towers 300 Barangaroo Avenue Level 24 Sydney NS 2000 Phone: 61.2.9472.4101 Fax: n/a http://www.kaziatherapeutics.com |
| Earnings (1year) ($): | -0.83 |
|---|---|
| Annual Dividend ($): | 0.00 |
| Current P/E Ratio (ttm): | n/a |
| Book Value ($): | 0.35 |
| Cash Flow ($): | -0.55 |
| Price/Earnings (x): | n/a |
|---|---|
| Price/Sales (x): | n/a |
| Price/Book (x): | 3.30 |
| Price/Cash Flow (x): | n/a |
| Quick Ratio (x): | 1.42 |
|---|---|
| Current Ratio (x): | 1.42 |
| LT Debt/Equity (x): | 0.00 |
| Total Debt/Equity (x): | 14.91 |
